Researchers at Mount Sinai and Memorial Sloan Kettering believe they’ve made a breakthrough in a new form of cancer treatment ...

Patients of European ancestry are more likely to find a match to the latest targeted cancer drugs than patients of other ...

A collaborative effort between Mount Sinai and Memorial Sloan Kettering Cancer Center has shed valuable light on how ...

An expanding body of research indicates that aerobic exercise and strength-training can improve the chances of survival.

In an intriguing revelation from recent research, mitochondria have been shown not only to power the cell but also to ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will ...

Researchers at The Tisch Cancer Institute at Mount Sinai, in collaboration with Memorial Sloan Kettering Cancer Center (MSK), ...

The age of testing for colorectal cancer has been pushed from 50 to 45, and it is even earlier for at-risk patients because of the rise in the number of young adults being diagnosed with the disease.

Determining which cancer patients are a good candidate for immune checkpoint inhibitors can be a challenge, but researchers at Mount Sinai and Memorial Sloan Kettering Cancer Center have developed a ...

Oncologist David Chung is taking on Northwell Health's newly established role of director of clinical research at its cancer ...

The Brian and Sheila Jellison Family Foundation is proud to be the first major donor to support Cancer Vaccine Coalition (CVC ...

Doctors around the world may soon have access to a new tool that could better predict whether individual cancer patients will benefit from immune checkpoint inhibitors - a type of immunotherapy - ...